This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solano, C.
Right arrow Articles by Gimeno, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solano, C.
Right arrow Articles by Gimeno, C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2001, p. 3938-3941, Vol. 39, No. 11
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.11.3938-3941.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Qualitative Plasma PCR Assay (AMPLICOR CMV Test) versus pp65 Antigenemia Assay for Monitoring Cytomegalovirus Viremia and Guiding Preemptive Ganciclovir Therapy in Allogeneic Stem Cell Transplantation

Carlos Solano,1 Isabel Muñoz,2 Antonio Gutiérrez,1 Amparo Farga,2 Felipe Prósper,1 Javier García-Conde,1 David Navarro,2,* and Concepción Gimeno2

Department of Hematology and Medical Oncology1 and Department of Microbiology,2 University Clinic Hospital, Valencia, Spain

Received 25 May 2001/Returned for modification 18 July 2001/Accepted 21 August 2001

The performances of a commercially available qualitative plasma PCR assay (AMPLICOR CMV test; Roche Diagnostics) and the pp65 antigenemia assay (AG) were evaluated for the monitoring of cytomegalovirus (CMV) viremia in 43 allogeneic stem cell transplant recipients. In addition, the suitabilities of both assays for triggering the initiation of preemptive ganciclovir therapy were assessed. A total of 37 CMV viremic episodes were detected in 28 patients. Positivity of plasma PCR testing in one or more consecutive specimens was the only marker of CMV viremia in 18 of the 37 episodes (PCR positive and AG negative, n = 50 specimens). Five episodes were diagnosed on the basis of a single positive AG result (AG positive and PCR negative, n = 5 specimens); both assays were eventually positive (PCR positive and AG positive, n = 27 specimens) for 14 viremic episodes; for these episodes, conversion of the PCR assay result to a positive result occurred an average of 1 week before conversion of the AG result. Overall, the concordance between the two methods was 90%, and the sensitivities of the plasma PCR assay and AG for the detection of CMV viremic episodes were 86.5 and 51.3%, respectively. Two patients who tested positive by both assays simultaneously progressed to CMV end-stage organ disease, despite the initiation of preemptive ganciclovir therapy. Conversion of the AG result to a negative result upon administration of preemptive ganciclovir therapy occurred a median of 7.5 days earlier than conversion of the plasma PCR assay result. Nineteen of the 28 patients with CMV viremia received AG-guided preemptive ganciclovir therapy; had the positivity of the plasma PCR assay triggered the initiation of preemptive therapy, 9 additional patients would have been unnecessarily treated since none of them developed CMV end-stage organ disease. Although the AMPLICOR CMV assay is more sensitive than AG, the latter appears to be more suitable both for guiding the initiation of preemptive therapy and for monitoring a patient's response to antiviral therapy.

* Corresponding author. Mailing address: Departamento de Microbiología, Hospital Clínico Universitario, Blasco Ibañez 17, 46010-Valencia, Spain. Phone: 34(96)3864657. Fax: 34(96)3864173. E-mail: David.Navarro{at}uv.es.

Journal of Clinical Microbiology, November 2001, p. 3938-3941, Vol. 39, No. 11
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.11.3938-3941.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gimeno, C., Solano, C., Latorre, J. C., Hernandez-Boluda, J. C., Clari, M. A., Remigia, M. J., Furio, S., Calabuig, M., Tormo, N., Navarro, D. (2008). Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection and Guidance of Preemptive Therapy for Allogeneic Hematopoietic Stem Cell Transplant Recipients. J. Clin. Microbiol. 46: 3311-3318 [Abstract] [Full Text]  
  • Solano, C., Benet, I., Clari, M. A., Nieto, J., de la Camara, R., Lopez, J., Hernandez-Boluda, J. C., Remigia, M. J., Jarque, I., Calabuig, M. L., Garcia-Noblejas, A., Alberola, J., Tamarit, A., Gimeno, C., Navarro, D. (2008). Enumeration of cytomegalovirus-specific interferon{gamma} CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection. haematol 93: 1434-1436 [Full Text]  
  • Einsele, H., Reusser, P., Bornhauser, M., Kalhs, P., Ehninger, G., Hebart, H., Chalandon, Y., Kroger, N., Hertenstein, B., Rohde, F., for the EBMT Working Group on Infectious Disease, (2006). Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation. Blood 107: 3002-3008 [Abstract] [Full Text]  
  • Meijer, E., Boland, G. J., Verdonck, L. F. (2003). Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants. Clin. Microbiol. Rev. 16: 647-657 [Abstract] [Full Text]  
  • Kaiser, L., Perrin, L., Chapuis, B., Hadaya, K., Kolarova, L., Deffernez, C., Huguet, S., Helg, C., Wunderli, W. (2002). Improved Monitoring of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation by an Ultrasensitive Plasma DNA PCR Assay. J. Clin. Microbiol. 40: 4251-4255 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»